PRECLINICAL DEVELOPMENT OF LUPIDUMAB, A TRANSFORMING NEW THERAPY FOR CHRONIC LYMPHOCYTIC LEUKAEMIA

Grant number: 1171598 | Funding period: 2020 - 2020

Completed